nach oben

Reviews in Endocrine and Metabolic Disorders

Erschienen in:

20.10.2016

Skin steroidogenesis in health and disease

verfasst von: Georgios Nikolakis, Constantine A. Stratakis, Theodora Kanaki, Andrej Slominski, Christos C. Zouboulis

Erschienen in: Reviews in Endocrine and Metabolic Disorders | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

The skin is an important extra-gonadal steroidogenic organ, capable of metabolizing various hormones from their precursors, as well as of synthesizing de novo a broad palette of sex steroids and glucocorticoids from cholesterol. In this manuscript, we review the major steroidogenic properties of human skin and we suggest steroidogenesis’ impairment as a cardinal factor for various pathological conditions such as acne, rosacea, atopic dermatitis, and androgenic alopecia.

Zouboulis CC. Acne Vulgaris and Rosacea. In: Granstein R, Luger T, editors. Neuroimmunology of the skin. Berlin Heidelberg: Springer; 2009. p. 219–32.CrossRef

Chen WC, Zouboulis CC. Hormones and the pilosebaceous unit. Dermato-Endocrinol. 2009;1(2):81–6.CrossRef

Zouboulis CC. Human skin: an independent peripheral endocrine organ. Horm Res. 2000;54(5–6):230–42.PubMed

Buske-Kirschbaum A, Ebrecht M, Hellhammer DH. Blunted HPA axis responsiveness to stress in atopic patients is associated with the acuity and severeness of allergic inflammation. Brain Behav Immun. 2010;24(8):1347–53.PubMedCrossRef

Skobowiat C, Dowdy JC, Sayre RM, Tuckey RC, Slominski AT. Cutaneous hypothalamic pituitary adrenal (HPA) axis homologue - regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab. 2011. doi:10.1152/ajpendo.00217.2011.PubMedPubMedCentral

Skobowiat C, Dowdy JC, Sayre RM, Tuckey RC, Slominski A. Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiation. Am J Physiol Endocrinol Metab. 2011;301(3):E484–93. doi:10.1152/ajpendo.00217.2011.10.1152/ajpendo.00217.2011.PubMedPubMedCentralCrossRef

Slominski A, Wortsman J, Tuckey RC, Paus R. Differential expression of HPA axis homolog in the skin. Mol Cell Endocrinol. 2007;265–266:143–9.PubMedCrossRef

Gadek-Michalska A, Tadeusz J, Rachwalska P, Spyrka J, Bugajski J. Effect of prior stress on interleukin-1beta and HPA axis responses to acute stress. Pharmacol Rep : PR. 2011;63(6):1393–403.PubMedCrossRef

Ito N, Ito T, Kromminga A, Bettermann A, Takigawa M, Kees F, et al. Human hair follicles display a functional equivalent of the hypothalamic-pituitary-adrenal axis and synthesize cortisol. FASEB J. 2005;19(10):1332–4. doi:10.1096/fj.04-1968fje.PubMed

10.

Slominski A, Zbytek B, Nikolakis G, Manna PR, Skobowiat C, Zmijewski M, et al. Steroidogenesis in the skin: Implications for local immune functions. J Steroid Biochem Mol Biol. 2013;137:107–23. doi:10.1016/j.jsbmb.2013.02.006.PubMedPubMedCentralCrossRef

11.

Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996;17(3):221–44.PubMed

12.

Manna PR, Stocco DM. Regulation of the steroidogenic acute regulatory protein expression: functional and physiological consequences. Curr Drug Targets Immune Endocr - Metabol Disord. 2005;5(1):93–108.PubMedCrossRef

13.

Miller WL, Bose HS. Early steps in steroidogenesis: intracellular cholesterol trafficking. J Lipid Res. 2011;52(12):2111–35. doi:10.1194/jlr.R016675.PubMedPubMedCentralCrossRef

14.

Slominski A, Zjawiony J, Wortsman J, Semak I, Stewart J, Pisarchik A, et al. A novel pathway for sequential transformation of 7-dehydrocholesterol and expression of the P450scc system in mammalian skin. Europ J Biochem / FEBS. 2004;271(21):4178–88.CrossRef

15.

Thiboutot D, Jabara S, McAllister JM, Sivarajah A, Gilliland K, Cong Z, et al. Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1). J Invest Dermatol. 2003;120(6):905–14.PubMedCrossRef

16.

Chen W, Tsai SJ, Liao CY, Tsai RY, Chen YJ, Pan BJ, et al. Higher levels of steroidogenic acute regulatory protein and type I 3beta-hydroxysteroid dehydrogenase in the scalp of men with androgenetic alopecia. J Invest Dermatol. 2006;126(10):2332–5. doi:10.1038/sj.jid.5700442.PubMedCrossRef

17.

Tiala I, Suomela S, Huuhtanen J, Wakkinen J, Holtta-Vuori M, Kainu K, et al. The CCHCR1 (HCR) gene is relevant for skin steroidogenesis and downregulated in cultured psoriatic keratinocytes. J Mol Med (Berl). 2007;85(6):589–601.CrossRef

18.

Hannen RF, Michael AE, Jaulim A, Bhogal R, Burrin JM, Philpott MP. Steroid synthesis by primary human keratinocytes; implications for skin disease. Biochem Biophys Res Commun. 2011;404(1):62–7. doi:10.1016/j.bbrc.2010.11.059.PubMedCrossRef

19.

Inoue T, Miki Y, Abe K, Hatori M, Hosaka M, Kariya Y, et al. Sex steroid synthesis in human skin in situ: the roles of aromatase and steroidogenic acute regulatory protein in the homeostasis of human skin. Mol Cell Endocrinol. 2012;362(1–2):19–28. doi:10.1016/j.mce.2012.05.005.PubMedCrossRef

20.

Patel MV, McKay IA, Burrin JM. Transcriptional regulators of steroidogenesis, DAX-1 and SF-1, are expressed in human skin. J Invest Dermatol. 2001;117(6):1559–65. doi:10.1046/j.0022-202x.2001.01587.x.PubMedCrossRef

21.

Manna PR, Eubank DW, Lalli E, Sassone-Corsi P, Stocco DM. Transcriptional regulation of the mouse steroidogenic acute regulatory protein gene by the cAMP response-element binding protein and steroidogenic factor 1. J Mol Endocrinol. 2003;30(3):381–97.PubMedCrossRef

22.

Manna PR, Dyson MT, Jo Y, Stocco DM. Role of dosage-sensitive sex reversal, adrenal hypoplasia congenita, critical region on the X chromosome, gene 1 in protein kinase A- and protein kinase C-mediated regulation of the steroidogenic acute regulatory protein expression in mouse Leydig tumor cells: mechanism of action. Endocrinology. 2009;150(1):187–99. doi:10.1210/en.2008-0368.PubMedCrossRef

23.

Thiboutot D, Chen W. Update and future of hormonal therapy in acne. Dermatology. 2003;206(1):57–67.PubMedCrossRef

24.

Chen W, Yang CC, Liao CY, Hung CL, Tsai SJ, Chen KF, et al. Expression of sex-determining genes in human sebaceous glands and their possible role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2006;20(7):846–52. doi:10.1111/j.1468-3083.2006.01663.x.PubMed

25.

Manna PR, Stetson CL, Daugherty C, Shimizu I, Syapin PJ, Garrel G, et al. Up-regulation of steroid biosynthesis by retinoid signaling: implications for aging. Mech Ageing Dev. 2015;150:74–82. doi:10.1016/j.mad.2015.08.007.PubMedPubMedCentralCrossRef

26.

Slominski A, Ermak G, Mihm M. ACTH receptor, CYP11A1, CYP17 and CYP21A2 genes are expressed in skin. J Clin Endocrinol Metab. 1996;81(7):2746–9.PubMed

27.

Slominski A, Gomez-Sanchez CE, Foecking MF, Wortsman J. Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett. 1999;455(3):364–6.PubMedCrossRef

28.

Slominski A, Gomez-Sanchez C, Foecking MF, Wortsman J. Active steroidogenesis in the normal rat skin. Biochim Biophys Acta. 2000;1474:1–4.PubMedCrossRef

29.

Slominski A, Zbytek B, Semak I, Sweatman T, Wortsman J. CRH stimulates POMC activity and corticosterone production in dermal fibroblasts. J Neuroimmunol. 2005;162(1–2):97–102.PubMedCrossRef

30.

Slominski A, Zbytek B, Szczesniewski A, Semak I, Kaminski J, Sweatman T, et al. CRH stimulation of corticosteroids production in melanocytes is mediated by ACTH. Am J Physiol Endocrinol Metab. 2005;288(4):E701–6.PubMedCrossRef

31.

Slominski A, Zbytek B, Szczesniewski A, Wortsman J. Cultured human dermal fibroblasts do produce cortisol. J Invest Dermatol. 2006;126(5):1177–8.PubMedPubMedCentralCrossRef

32.

Rogoff D, Gomez-Sanchez CE, Foecking MF, Wortsman J, Slominski A. Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol. 2001;78(1):77–81.PubMedCrossRef

33.

Slominski A, Wortsman J, Foecking MF, Shackleton C, Gomez-Sanchez C, Szczesniewski A. Gas chromatography/mass spectrometry characterization of corticosteroid metabolism in human immortalized keratinocytes. J Invest Dermatol. 2002;118(2):310–5. doi:10.1046/j.0022-202x.2001.01648.x.PubMedCrossRef

34.

Sharpley CF, Kauter KG, McFarlane JR. An initial exploration of in vivo hair cortisol responses to a brief pain stressor: latency, localization and independence effects. Physiol Res. 2009;58(5):757–61.PubMed

35.

Vukelic S, Stojadinovic O, Pastar I, Rabach M, Krzyzanowska A, Lebrun E, et al. Cortisol synthesis in epidermis is induced by IL-1 and tissue injury. J Biol Chem. 2011;286(12):10265–75. doi:10.1074/jbc.M110.188268.PubMedPubMedCentralCrossRef

36.

Cirillo N, Prime SS. Keratinocytes synthesize and activate cortisol. J Cell Biochem. 2011;112(6):1499–505. doi:10.1002/jcb.23081.PubMedCrossRef

37.

Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Res. 2011;32(1):81–151. doi:10.1210/er.2010-0013.CrossRef

38.

Tiganescu A, Walker EA, Hardy RS, Mayes AE, Stewart PM. Localization, age- and site-dependent expression, and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in skin. J Invest Dermatol. 2011;131(1):30–6. doi:10.1038/jid.2010.257.PubMedCrossRef

39.

Skobowiat C, Sayre RM, Dowdy JC, Slominski AT. Ultraviolet radiation regulates cortisol activity in a waveband dependent manner in human skin ex-vivo. Br J Dermatol. 2013;in press.

40.

Proksch E, Feingold KR, Elias PM. Epidermal HMG CoA reductase activity in essential fatty acid deficiency: barrier requirements rather than eicosanoid generation regulate cholesterol synthesis. J Invest Dermatol. 1992;99(2):216–20.PubMedCrossRef

41.

Cassidy DM, Lee CM, Laker MF, Kealey T. Lipogenesis in isolated human sebaceous glands. FEBS Lett. 1986;200(1):173–6.PubMedCrossRef

42.

Alesci S, Koch CA, Bornstein SR, Pacak K. Adrenal androgens regulation and adrenopause. Endocr Regul. 2001;35(2):95–100.PubMed

43.

Zouboulis CC, Chen WC, Thornton MJ, Qin K, Rosenfield R. Sexual hormones in human skin. Hormone Meta Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2007;39(2):85–95. doi:10.1055/s-2007-961807.CrossRef

44.

Stocco DM, Wang X, Jo Y, Manna PR. Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought. Mol Endocrinol. 2005;19(11):2647–59.PubMedCrossRef

45.

Manna PR, Dyson MT, Eubank DW, Clark BJ, Lalli E, Sassone-Corsi P, et al. Regulation of steroidogenesis and the steroidogenic acute regulatory protein by a member of the cAMP response-element binding protein family. Mol Endocrinol. 2002;16(1):184–99.PubMedCrossRef

46.

Manna PR, Dyson MT, Stocco DM. Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives. Mol Hum Reprod. 2009;15(6):321–33. doi:10.1093/molehr/gap025.PubMedPubMedCentralCrossRef

47.

Chen W, Tsai SJ, Sheu HM, Tsai JC, Zouboulis CC. Testosterone synthesized in cultured human SZ95 sebocytes derives mainly from dehydroepiandrosterone. Exp Dermatol. 2010;19(5):470–2. doi:10.1111/j.1600-0625.2009.00996.x.PubMedCrossRef

48.

Milewich L, Sontheimer RD, Herndon Jr JH. Steroid sulfatase activity in epidermis of acne-prone and non-acne-prone skin of patients with acne vulgaris. Arch Dermatol. 1990;126(10):1312–4.PubMedCrossRef

49.

Hoffmann R, Rot A, Niiyama S, Billich A. Steroid sulfatase in the human hair follicle concentrates in the dermal papilla. J Invest Dermatol. 2001;117(6):1342–8. doi:10.1046/j.0022-202x.2001.01547.x.PubMedCrossRef

50.

Billich A, Rot A, Lam C, Schmidt JB, Schuster I. Immunohistochemical localization of steroid sulfatase in acne lesions: implications for the contribution of dehydroepiandrosterone sulfate to the pathogenesis of acne. Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2000;53:99.

51.

Fritsch M, Orfanos CE, Zouboulis CC. Sebocytes are the key regulators of androgen homeostasis in human skin. J Invest Dermatol. 2001;116(5):793–800. doi:10.1046/j.0022-202x.2001.doc.x.PubMedCrossRef

52.

Thiboutot D. Acne: hormonal concepts and therapy. Clin Dermatol. 2004;22(5):419–28. doi:10.1016/j.clindermatol.2004.03.010.PubMedCrossRef

53.

Labrie F, Luu-The V, Labrie C, Pelletier G, El-Alfy M. Intracrinology and the skin. Horm Res. 2000;54(5–6):218–29.PubMed

54.

Chen W, Thiboutot D, Zouboulis CC. Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol. 2002;119(5):992–1007. doi:10.1046/j.1523-1747.2002.00613.x.PubMedCrossRef

55.

Thiboutot D, Martin P, Volikos L, Gilliland K. Oxidative activity of the type 2 isozyme of 17beta-hydroxysteroid dehydrogenase (17beta-HSD) predominates in human sebaceous glands. J Invest Dermatol. 1998;111(3):390–5. doi:10.1046/j.1523-1747.1998.00322.x.PubMedCrossRef

56.

Sakurai N, Miki Y, Suzuki T, Watanabe K, Narita T, Ando K, et al. Systemic distribution and tissue localizations of human 17beta-hydroxysteroid dehydrogenase type 12. J Steroid Biochem Mol Biol. 2006;99(4–5):174–81. doi:10.1016/j.jsbmb.2006.01.010.PubMedCrossRef

57.

Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V. Characteristics of a highly labile human type 5 17beta-hydroxysteroid dehydrogenase. Endocrinology. 1999;140(2):568–74.PubMed

58.

Courchay G, Boyera N, Bernard BA, Mahe Y. Messenger RNA expression of steroidogenesis enzyme subtypes in the human pilosebaceous unit. Skin Pharmacol. 1996;9(3):169–76.PubMedCrossRef

59.

Qin KN, New MI, Cheng KC. Molecular cloning of multiple cDNAs encoding human enzymes structurally related to 3 alpha-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol. 1993;46(6):673–9.PubMedCrossRef

60.

Brodie A, Inkster S, Yue W. Aromatase expression in the human male. Mol Cell Endocrinol. 2001;178(1–2):23–8.PubMedCrossRef

61.

Andersson S, Russell DW. Structural and biochemical properties of cloned and expressed human and rat steroid 5 alpha-reductases. Proc Natl Acad Sci U S A. 1990;87(10):3640–4.PubMedPubMedCentralCrossRef

62.

Grino PB, Griffin JE, Wilson JD. Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. Endocrinology. 1990;126(2):1165–72.PubMedCrossRef

63.

Chen W, Zouboulis CC, Fritsch M, Blume-Peytavi U, Kodelja V, Goerdt S, et al. Evidence of heterogeneity and quantitative differences of the type 1 5alpha-reductase expression in cultured human skin cells--evidence of its presence in melanocytes. J Invest Dermatol. 1998;110(1):84–9. doi:10.1046/j.1523-1747.1998.00080.x.PubMedCrossRef

64.

Deplewski D, Rosenfield RL. Role of hormones in pilosebaceous unit development. Endocr Rev. 2000;21(4):363–92.PubMedCrossRef

65.

Lai JJ, Chang P, Lai KP, Chen L, Chang C. The role of androgen and androgen receptor in skin-related disorders. Arch Dermatol Res. 2012;304(7):499–510. doi:10.1007/s00403-012-1265-x.PubMedPubMedCentralCrossRef

66.

Seiffert K, Seltmann H, Fritsch M, Zouboulis CC. Inhibition of 5alpha-reductase activity in SZ95 sebocytes and HaCaT keratinocytes in vitro. Hormone Metab Res = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 2007;39(2):141–8. doi:10.1055/s-2007-961814.PubMedCrossRef

67.

Uemura M, Tamura K, Chung S, Honma S, Okuyama A, Nakamura Y, et al. Novel 5 alpha-steroid reductase (SRD5A3, type-3) is overexpressed in hormone-refractory prostate cancer. Cancer Sci. 2008;99(1):81–6. doi:10.1111/j.1349-7006.2007.00656.x.PubMed

68.

Samson M, Labrie F, Zouboulis CC, Luu-The V. Biosynthesis of dihydrotestosterone by a pathway that does not require testosterone as an intermediate in the SZ95 sebaceous gland cell line. J Invest Dermatol. 2010;130(2):602–4. doi:10.1038/jid.2009.225.PubMedCrossRef

69.

Kanda N, Watanabe S. 17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J Invest Dermatol. 2004;123(2):319–28. doi:10.1111/j.0022-202X.2004.12645.x.PubMedCrossRef

70.

Raine-Fenning NJ, Brincat MP, Muscat-Baron Y. Skin aging and menopause : implications for treatment. Am J Clin Dermatol. 2003;4(6):371–8.PubMedCrossRef

71.

Bentley JP, Brenner RM, Linstedt AD, West NB, Carlisle KS, Rokosova BC, et al. Increased hyaluronate and collagen biosynthesis and fibroblast estrogen receptors in macaque sex skin. J Invest Dermatol. 1986;87(5):668–73.PubMedCrossRef

72.

Kanda N, Watanabe S. 17beta-estradiol enhances the production of granulocyte-macrophage colony-stimulating factor in human keratinocytes. J Invest Dermatol. 2004;123(2):329–37. doi:10.1111/j.0022-202X.2004.23231.x.PubMedCrossRef

73.

Thornton MJ. Oestrogen functions in skin and skin appendages. Expert Opin Ther Targets. 2005;9(3):617–29. doi:10.1517/14728222.9.3.617.PubMedCrossRef

74.

Kanda N, Watanabe S. Regulatory roles of sex hormones in cutaneous biology and immunology. J Dermatol Sci. 2005;38(1):1–7. doi:10.1016/j.jdermsci.2004.10.011.PubMedCrossRef

75.

Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, et al. Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev. 1994;15(3):342–55.PubMed

76.

Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev. 2009;30(4):343–75. doi:10.1210/er.2008-0016.PubMedCrossRef

77.

Pomari E, Dalla Valle L, Pertile P, Colombo L, Thornton MJ. Intracrine sex steroid synthesis and signaling in human epidermal keratinocytes and dermal fibroblasts. FASEB J. 2015;29(2):508–24. doi:10.1096/fj.14-251363fj.14-251363.PubMedCrossRef

78.

Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A. 1993;90(24):11673–7.PubMedPubMedCentralCrossRef

79.

Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, et al. Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab. 2007;92(3):982–90. doi:10.1210/jc.2006-1181.PubMedCrossRef

80.

Stratakis CA, Vottero A, Brodie A, Kirschner LS, DeAtkine D, Lu Q, et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab. 1998;83(4):1348–57. doi:10.1210/jcem.83.4.4697.PubMed

81.

Stratakis CA. An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors. J Clin Endocrinol Metab. 2013;98(12):4676–81. doi:10.1210/jc.2013-3990.PubMedPubMedCentralCrossRef

82.

Conrad F, Paus R. Estrogens and the hair follicle. J Dtsch Dermatol Ges. 2004;2(6):412–23.PubMedCrossRef

83.

Harada N. A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochem Biophys Res Commun. 1992;189(2):1001–7.PubMedCrossRef

84.

Falany CN. Sulfation and sulfotransferases. introduction: changing view of sulfation and the cytosolic sulfotransferases. FASEB J. 1997;11(1):1–2.PubMed

85.

Kushida A, Hattori K, Yamaguchi N, Kobayashi T, Date A, Tamura H. Sulfation of estradiol in human epidermal keratinocyte. Biol Pharm Bull. 2011;34(7):1147–51.PubMedCrossRef

86.

Ohnemus U, Uenalan M, Inzunza J, Gustafsson JA, Paus R. The hair follicle as an estrogen target and source. Endocr Rev. 2006;27(6):677–706. doi:10.1210/er.2006-0020.PubMedCrossRef

87.

Ma NS, Geffner ME. Gynecomastia in prepubertal and pubertal men. Curr Opin Pediatr. 2008;20(4):465–70. doi:10.1097/MOP.0b013e328305e415.PubMedCrossRef

88.

Balunas MJ, Su B, Brueggemeier RW, Kinghorn AD. Natural products as aromatase inhibitors. Anticancer Agents Med Chem. 2008;8.

89.

Brueggemeier RW, Hackett JC, Diaz-Cruz ES. Aromatase inhibitors in the treatment of breast cancer. Endocr Rev. 2005;26.

90.

Bulun SE, Lin Z, Imir G, Amin S, Demura M, Yilmaz B et al. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment. Pharmacol Rev. 2005;57.

91.

Bernard P, Scior T, Do QT. Modulating testosterone pathway: a new strategy to tackle male skin aging? Clin Interv Aging. 2012;7:351–61. doi:10.2147/CIA.S34034.PubMedPubMedCentral

92.

Caglayan AO, Dundar M, Tanriverdi F, Baysal NA, Unluhizarci K, Ozkul Y, et al. Idiopathic hirsutism: local and peripheral expression of aromatase (CYP19A) and 5alpha-reductase genes (SRD5A1 and SRD5A2). Fertil Steril. 2011;96(2):479–82. doi:10.1016/j.fertnstert.2011.05.040.PubMedCrossRef

93.

Thornton MJ, Taylor AH, Mulligan K, Al-Azzawi F, Lyon CC, O’Driscoll J, et al. Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol. 2003;12(2):181–90. doi:10.1034/j.1600-0625.2003.120209.x.PubMedCrossRef

94.

Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci U S A. 1986;83(8):2496–500.PubMedPubMedCentralCrossRef

95.

Verdier-Sevrain S, Yaar M, Cantatore J, Traish A, Gilchrest BA. Estradiol induces proliferation of keratinocytes via a receptor mediated mechanism. FASEB J. 2004;18(11):1252–4. doi:10.1096/fj.03-1088fje.PubMed

96.

Turgeon D, Carrier JS, Levesque E, Hum DW, Belanger A. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology. 2001;142(2):778–87.PubMed

97.

Tang W, Eggertsen G, Chiang JY, Norlin M. Estrogen-mediated regulation of CYP7B1: a possible role for controlling DHEA levels in human tissues. J Steroid Biochem Mol Biol. 2006;100(1–3):42–51. doi:10.1016/j.jsbmb.2006.02.005.PubMedCrossRef

98.

Zhu BT, Lee AJ. NADPH-dependent metabolism of 17beta-estradiol and estrone to polar and nonpolar metabolites by human tissues and cytochrome P450 isoforms. Steroids. 2005;70(4):225–44. doi:10.1016/j.steroids.2005.01.002.PubMedCrossRef

99.

Chouinard S, Yueh M-F, Tukey RH, Giton F, Fiet J, Pelletier G, et al. Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol. 2008;109(3–5):247–53. doi:10.1016/j.jsbmb.2008.03.016.PubMedCrossRef

100.

Belanger A, Hum DW, Beaulieu M, Levesque E, Guillemette C, Tchernof A, et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol. 1998;65(1–6):301–10.PubMedCrossRef

101.

Higashi Y, Fuda H, Yanai H, Lee Y, Fukushige T, Kanzaki T, et al. Expression of cholesterol sulfotransferase (SULT2B1b) in human skin and primary cultures of human epidermal keratinocytes. J Invest Dermatol. 2004;122(5):1207–13. doi:10.1111/j.0022-202X.2004.22416.x.PubMedCrossRef

102.

Falany CN, He D, Dumas N, Frost AR, Falany JL. Human cytosolic sulfotransferase 2B1: isoform expression, tissue specificity and subcellular localization. J Steroid Biochem Mol Biol. 2006;102(1–5):214–21. doi:10.1016/j.jsbmb.2006.09.011.PubMedPubMedCentralCrossRef

103.

Dooley TP, Walker CJ, Hirshey SJ, Falany CN, Diani AR. Localization of minoxidil sulfotransferase in rat liver and the outer root sheath of anagen pelage and vibrissa follicles. J Invest Dermatol. 1991;96(1):65–70.PubMedCrossRef

104.

Marin YE, Seiberg M, Lin CB. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival. Exp Dermatol. 2009;18(7):611–8. doi:10.1111/j.1600-0625.2008.00839.x.PubMedCrossRef

105.

Hennebert O, Chalbot S, Alran S, Morfin R. Dehydroepiandrosterone 7alpha-hydroxylation in human tissues: possible interference with type 1 11beta-hydroxysteroid dehydrogenase-mediated processes. J Steroid Biochem Mol Biol. 2007;104(3–5):326–33. doi:10.1016/j.jsbmb.2007.03.026.PubMedCrossRef

106.

Gollnick HP, Finlay AY, Shear N. Can we define acne as a chronic disease? if so, how and when? Am J Clin Dermatol. 2008;9(5):279–84.PubMedCrossRef

107.

Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. What is the pathogenesis of acne? Exp Dermatol. 2005;14(2):143–52.PubMedCrossRef

108.

Zampeli VA, Makrantonaki E, Tzellos T, Zouboulis CC. New pharmaceutical concepts for sebaceous gland diseases: implementing today’s pre-clinical data into tomorrow’s daily clinical practice. Curr Pharm Biotechnol. 2012;13(10):1898–913.PubMedCrossRef

109.

Zouboulis CC. Is acne vulgaris a genuine inflammatory disease? Dermatology. 2001;203(4):277–9.PubMedCrossRef

110.

Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22(5):360–6. doi:10.1016/j.clindermatol.2004.03.004.PubMedCrossRef

111.

Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, et al. New developments in our understanding of acne pathogenesis and treatment. Exp Dermatol. 2009;18(10):821–32. doi:10.1111/j.600-0625.2009.00890.x.PubMedCrossRef

112.

Ganceviciene R, Bohm M, Fimmel S, Zouboulis CC. The role of neuropeptides in the multifactorial pathogenesis of acne vulgaris. Dermatoendocrinology. 2009;1(3):170–6.CrossRef

113.

Oeff MK, Seltmann H, Hiroi N, Nastos A, Makrantonaki E, Bornstein SR, et al. Differential regulation of Toll-like receptor and CD14 pathways by retinoids and corticosteroids in human sebocytes. Dermatology. 2006;213(3):266. doi:10.1159/000095056.PubMedCrossRef

114.

Lai JJ, Lai KP, Chuang KH, Chang P, Yu IC, Lin WJ, et al. Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-alpha expression. J Clin Invest. 2009;119(12):3739–51. doi:10.1172/JCI3933539335.PubMedPubMedCentralCrossRef

115.

Lee WJ, Jung HD, Chi SG, Kim BS, Lee SJ, do Kim W. Effect of dihydrotestosterone on the upregulation of inflammatory cytokines in cultured sebocytes. Arch Dermatol Res. 2010;302(6):429–33. doi:10.1007/s00403-009-1019-6.PubMedCrossRef

116.

Zouboulis CC, Seltmann H, Hiroi N, Chen W, Young M, Oeff M, et al. Corticotropin-releasing hormone: an autocrine hormone that promotes lipogenesis in human sebocytes. Proc Natl Acad Sci U S A. 2002;99(10):7148–53. doi:10.1073/pnas.10218099999/10/7148.PubMedPubMedCentralCrossRef

117.

Lucky AW. A review of infantile and pediatric acne. Dermatology. 1998;196(1):95–7.PubMedCrossRef

118.

Zouboulis CC. Acne as a chronic systemic disease. Clin Dermatol. 2014;32(3):389–96. doi:10.1016/j.clindermatol.2013.11.005.PubMedCrossRef

119.

Imperato-McGinley J. 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Adv Exp Med Biol. 2002;511:121–31. discussion 31–4.PubMedCrossRef

120.

Eklof AC, Thurelius AM, Garle M, Rane A, Sjoqvist F. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology. Eur J Clin Pharmacol. 2003;59(8–9):571–7. doi:10.1007/s00228-003-0633-z.PubMedCrossRef

121.

Zouboulis CC, Seltmann H, Neitzel H, Orfanos CE. Establishment and characterization of an immortalized human sebaceous gland cell line (SZ95). J Invest Dermatol. 1999;113(6):1011–20. doi:10.1046/j.1523-1747.1999.00771.x.PubMedCrossRef

122.

Makrantonaki E, Zouboulis CC. Testosterone metabolism to 5alpha-dihydrotestosterone and synthesis of sebaceous lipids is regulated by the peroxisome proliferator-activated receptor ligand linoleic acid in human sebocytes. Br J Dermatol. 2007;156(3):428–32. doi:10.1111/j.1365-2133.2006.07671.x.PubMedCrossRef

123.

Zaidi Z. Acne vulgaris--an update on pathophysiology and treatment. J Pak Med Assoc. 2009;59(9):635–7.PubMed

124.

Thiboutot D, Bayne E, Thorne J, Gilliland K, Flanagan J, Shao Q, et al. Immunolocalization of 5alpha-reductase isozymes in acne lesions and normal skin. Arch Dermatol. 2000;136(9):1125–9.PubMedCrossRef

125.

Leyden J, Bergfeld W, Drake L, Dunlap F, Goldman MP, Gottlieb AB, et al. A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. J Am Acad Dermatol. 2004;50(3):443–7. doi:10.1016/j.jaad.2003.07.021.PubMedCrossRef

126.

Saito H. Much atopy about the skin: genome-wide molecular analysis of atopic eczema. Int Arch Allergy Immunol. 2005;137(4):319–25.PubMedCrossRef

127.

Bolognia JL, Schaffer JV, Duncan KO, Ko CJ. Dermatology Essentials E- Book. Elsevier Health Sciences; 2014.

128.

Kono M, Nomura T, Ohguchi Y, Mizuno O, Suzuki S, Tsujiuchi H, et al. Comprehensive screening for a complete set of Japanese-population-specific filaggrin gene mutations. Allergy. 2014;69(4):537–40. doi:10.1111/all.12369.PubMedCrossRef

129.

Yamanaka K, Mizutani H. The role of cytokines/chemokines in the pathogenesis of atopic dermatitis. Curr Probl Dermatol. 2011;41:80–92.PubMedCrossRef

130.

Sevilla LM, Latorre V, Sanchis A, Perez P. Epidermal Inactivation of the Glucocorticoid Receptor Triggers Skin Barrier Defects and Cutaneous Inflammation. J Invest Dermatol. 2012.

131.

Powell FC. Clinical practice. Rosacea N Engl J Med. 2005;352(8):793–803. doi:10.1056/NEJMcp042829.PubMedCrossRef

132.

Kurkcuoglu N, Alaybeyi F. Substance P immunoreactivity in rosacea. J Am Acad Dermatol. 1991;25(4):725–6.PubMedCrossRef

133.

Powell FC, Corbally N, Powell D. Substance P and rosacea. J Am Acad Dermatol. 1993;28(1):132–3.PubMedCrossRef

134.

Wollina U. Rhinophyma--unusual expression of simple-type keratins and S100A in sebocytes and abundance of VIP receptor-positive dermal cells. Histol Histopathol. 1996;11(1):111–5.PubMed

135.

Slominski A. On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol. 2009;160(2):229–32. doi:10.1111/j.1365-2133.2008.08958.x.PubMedPubMedCentralCrossRef

136.

Murphy G. Ultraviolet light and rosacea. Cutis. 2004;74(3 Suppl):13–6. 32–4.PubMed

137.

Yano K, Kadoya K, Kajiya K, Hong YK, Detmar M. Ultraviolet B irradiation of human skin induces an angiogenic switch that is mediated by upregulation of vascular endothelial growth factor and by downregulation of thrombospondin-1. Br J Dermatol. 2005;152(1):115–21. doi:10.1111/j.1365-2133.2005.06368.x.PubMedCrossRef

138.

Nikolakis G, Zouboulis CC. Skin and glucocorticoids: effects of local skin glucocorticoid impairment on skin homeostasis. Exp Dermatol. 2014;23(11):807–8.PubMedCrossRef

139.

Zbytek B, Wortsman J, Slominski A. Characterization of a ultraviolet B-induced corticotropin-releasing hormone-proopiomelanocortin system in human melanocytes. Mol Endocrinol. 2006;20(10):2539–47. doi:10.1210/me.2006-0116.PubMedPubMedCentralCrossRef

140.

Slominski AT, Manna PR, Tuckey RC. Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity. Exp Dermatol. 2014;23(6):369–74. doi:10.1111/exd.12376.PubMedPubMedCentralCrossRef

141.

Skobowiat C, Sayre RM, Dowdy JC, Slominski AT. Ultraviolet radiation regulates cortisol activity in a waveband-dependent manner in human skin ex vivo. Br J Dermatol. 2013;168(3):595–601. doi:10.1111/bjd.12096.PubMedPubMedCentralCrossRef

142.

Karagas MR, Cushing Jr GL, Greenberg ER, Mott LA, Spencer SK, Nierenberg DW. Non-melanoma skin cancers and glucocorticoid therapy. Br J Cancer. 2001;85(5):683–6. doi:10.1054/bjoc.2001.1931.PubMedPubMedCentralCrossRef

143.

Karimi K, Lindgren TH, Koch CA, Brodell RT. Obesity as risk factor for malignant melanoma and non-melanoma skin cancer. Rev Endocr Metab Disord. 2016.

144.

Zhou JH, Kim KB, Myers JN, Fox PS, Ning J, Bassett RL, et al. Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol. 2014;36(1):74–9. doi:10.1097/DAD.0b013e3182914c64.PubMedPubMedCentralCrossRef

145.

Slominski AT, Zmijewski MA, Semak I, Zbytek B, Pisarchik A, Li W, et al. Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem. 2014;14(1):77–96.PubMedPubMedCentralCrossRef

146.

Hawkins EF, Horn D, Markland Jr FS. Receptor for glucocorticoids in RPMI 3460 melanoma cells. Cancer Res. 1980;40(7):2174–8.PubMed

147.

Rampen FH. Comments on the contribution by H. J. Grill et al. Steroid hormone receptors in melanoma. Arch Dermatol Res. 1983;275(3):208–9.PubMedCrossRef

148.

Grill HJ, Benes P, Manz B, Schramm P, Morsches B, Korting GW, et al. Steroid hormone receptors in human melanoma. Arch Dermatol Res. 1982;272(1–2):97–101.PubMed

149.

Neifeld JP, Lippman ME. Steroid hormone receptors and melanoma. J Invest Dermatol. 1980;74(6):379–81.PubMedCrossRef

150.

Nasabzadeh TJ, Stefanato CM, Doole JE, Radfar A, Bhawan J, Venna S. Recurrent erythema multiforme triggered by progesterone sensitivity. J Cutan Pathol. 2010;37(11):1164–7. doi:10.1111/j.1600-0560.2010.01607.x.PubMedCrossRef

151.

Nguyen T, Razzaque Ahmed A. Autoimmune progesterone dermatitis: update and insights. Autoimmun Rev. 2016;15(2):191–7. doi:10.1016/j.autrev.2015.11.003.PubMedCrossRef

152.

Hill JL, Carr TF. Iatrogenic autoimmune progesterone dermatitis treated with a novel intramuscular progesterone desensitization protocol. J Allergy Clin Immunol Pract. 2013;1(5):537–8. doi:10.1016/j.jaip.2013.06.005.PubMedCrossRef

153.

Prieto-Garcia A, Sloane DE, Gargiulo AR, Feldweg AM, Castells M. Autoimmune progesterone dermatitis: clinical presentation and management with progesterone desensitization for successful in vitro fertilization. Fertil Steril. 2011;95(3):1121 e9–13. doi:10.1016/j.fertnstert.2010.10.038.CrossRef

154.

McCalmont TH. Fact or fiction? J Cutan Pathol. 2010;37(11):1130–1. doi:10.1111/j.1600-0560.2010.01616.x.PubMedCrossRef

155.

Solomon M, Itsekson AM, Lev-Sagie A. Autoimmune progesterone dermatitis. Curr Dermatol Rep. 2013;2(4):258–63. doi:10.1007/s13671-013-0059-5.CrossRef

156.

Batrinos ML. The endocrinology of baldness. Hormones (Athens). 2014;13(2):197–212.

157.

Zouboulis CC. The skin as an endocrine organ. Dermatoendocrinology. 2009;1(5):250–2.CrossRef

158.

Hibberts NA, Howell AE, Randall VA. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp. J Endocrinol. 1998;156(1):59–65.PubMedCrossRef

159.

Chen W, Yang CC, Tsai RY, Liao CY, Yen YT, Hung CL, et al. Expression of sex-determining genes in the scalp of men with androgenetic alopecia. Dermatology. 2007;214(3):199–204.PubMedCrossRef

160.

Sawaya ME, Price VH. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol. 1997;109(3):296–300.PubMedCrossRef

161.

Lee MJ, Cha HJ, Lim KM, Lee OK, Bae S, Kim CH, et al. Analysis of the microRNA expression profile of normal human dermal papilla cells treated with 5alpha-dihydrotestosterone. Mol Med Rep. 2015;12(1):1205–12. doi:10.3892/mmr.2015.3478.PubMed

162.

Conrad F, Ohnemus U, Bodo E, Bettermann A, Paus R. Estrogens and human scalp hair growth-still more questions than answers. J Invest Dermatol. 2004;122(3):840–2. doi:10.1111/j.0022-202X.2004.22344.x.PubMedCrossRef

163.

Hoffmann R, Niiyama S, Huth A, Kissling S, Happle R. 17alpha-estradiol induces aromatase activity in intact human anagen hair follicles ex vivo. Exp Dermatol. 2002;11(4):376–80.PubMedCrossRef

Titel: Skin steroidogenesis in health and disease
verfasst von: Georgios Nikolakis
Constantine A. Stratakis
Theodora Kanaki
Andrej Slominski
Christos C. Zouboulis
Publikationsdatum: 20.10.2016
Verlag: Springer US
Erschienen in: Reviews in Endocrine and Metabolic Disorders / Ausgabe 3/2016
Print ISSN: 1389-9155
Elektronische ISSN: 1573-2606
DOI: https://doi.org/10.1007/s11154-016-9390-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Neuroendocrinology of the skin

Stress-related skin disorders

Targeting the vitamin D endocrine system (VDES) for the management of inflammatory and malignant skin diseases: An historical view and outlook

Skin manifestations of Cushing’s syndrome

Skin manifestations of growth hormone-induced diseases